Not really, but I’d imagine that headline caught your eye and grabbed your attention, which is what it was supposed to do. The study on which that claim is based was widely and often quite misleadingly trumpeted across the Internet yesterday (July 6, 2009). Although some responsible sites included in the headline that the tests were done in mice, many concealed this important fact until you were well into the article and had already been exposed to whatever advertising was on the page. I’d already seen several misleading headlines before I realized the studies were in mice and I’m sure that many people didn’t ever get the full story.
The entire webisode was set in motion by the University of South Florida Health’s press release, a slick piece of PR entitled “Caffeine reverses memory impairment in Alzheimer’s mice,” based on research done at that institution. At least they got it right. […]
Original post by admin and weightlossopinions.com
Using someone else’s prescription medicine is a lot like playing Russian roulette – you might get away unscathed, and then again you might not. And it could have devastating consequences. Just because we see prescription medicines advertised on TV doesn’t mean they are safe for everyone. There are good reasons why you can’t buy them over the counter. A physician takes many factors into account before prescribing a medication for you, including your current condition, your past medical history, your other medications and the likely risks and benefits of the drug to you as an individual. After making this decision he or she will then explain how to take the medication, when to take it, how much and how long to take it, what else you can and can’t take with it, and what to expect after you take it – both the good and the bad. And after all […]
Original post by admin and weightlossopinions.com
The antidepressant Cymbalta (duloxetine), marketed by Lilly, has received FDA approval for the treatment of fibromyalgia. While certain antidepressants are considered first-line therapy for fibromyalgia, most notably the tricyclic antidepressants such as amitriptyline, none had been approved by the FDA for this use until now. Cymbalta belongs to a newer class of antidepressants known collectively as serotonin and norepinephrine reuptake inhibitors (SNRIs), which are somewhat similar to the serotonin reuptake inhibitors (SSRIs), of which Prozac, also marketed by Lilly, is the most widely known. Cymbalta is already marketed for the treatment of depression, anxiety and for pain associated with diabetic peripheral neuropathy. It was first approved for U.S. marketing in 2004.
Cymbalta is now the second drug approved by the FDA for the treatment of fibromyalgia. Almost exactly one year ago the FDA approved Pfizer’s Lyrica (pregabalin) and I alerted readers to that approval in a posting; at […]
Original post by natalieb and weightlossopinions.com
